1. OpenAPS Outcomes [Available from: https://openaps.org/outcomes/.
2. FDA approves first automated insulin delivery device for type 1 diabetes (2016) [Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-automated-insulin-delivery-device-type-1-diabetes.
3. Certain Medtronic MiniMed Insulin Pumps Have Potential Cybersecurity Risks: FDA Safety Communication. FDA2019 (2019) [Available from: https://www.fda.gov/medical-devices/safety-communications/certain-medtronic-minimed-insulin-pumps-have-potential-cybersecurity-risks-fda-safety-communication.
4. Position statement: people with type 1 diabetes and do it yourself (DIY) technology solutions. Diabetes Australia2018 (2018)[Available from: https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/ee67e929-5ffc-411f-b286-1ca69e181d1a.pdf.
5. Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (2019) [Available from: https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-announces-fda-clearance-tslim-x2-insulin.